|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1136962379 |
| 003 |
OCoLC |
| 005 |
20231120010432.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
200120s2020 maua o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d OPELS
|d OCLCF
|d CS1
|d SCB
|d N$T
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 066 |
|
|
|c (S
|
| 020 |
|
|
|a 9780128186749
|q (electronic bk.)
|
| 020 |
|
|
|a 0128186747
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128186732
|
| 020 |
|
|
|z 0128186739
|
| 035 |
|
|
|a (OCoLC)1136962379
|
| 050 |
|
4 |
|a QR188.6
|
| 082 |
0 |
4 |
|a 616.99/4079
|2 23
|
| 245 |
0 |
0 |
|a Tumor immunology and immunotherapy :
|b cellular methods.
|n Part A /
|c edited by Lorenzo Galluzzi, Nils-Petter Rudqvist.
|
| 260 |
|
|
|a Cambridge, MA :
|b Academic Press,
|c 2020.
|
| 300 |
|
|
|a 1 online resource (xlii, 512 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in enzymology ;
|v v. 631
|
| 650 |
|
0 |
|a Cancer
|x Immunological aspects.
|
| 650 |
|
0 |
|a Cancer
|x Immunotherapy.
|
| 650 |
|
0 |
|a Tumors
|x Immunological aspects.
|
| 650 |
|
6 |
|a Cancer
|x Immunologie.
|0 (CaQQLa)201-0004695
|
| 650 |
|
6 |
|a Cancer
|x Immunoth�erapie.
|0 (CaQQLa)201-0168739
|
| 650 |
|
6 |
|a Tumeurs
|x Immunologie.
|0 (CaQQLa)201-0049657
|
| 650 |
|
7 |
|a Cancer
|x Immunological aspects
|2 fast
|0 (OCoLC)fst00845383
|
| 650 |
|
7 |
|a Cancer
|x Immunotherapy
|2 fast
|0 (OCoLC)fst00845386
|
| 650 |
|
7 |
|a Tumors
|x Immunological aspects
|2 fast
|0 (OCoLC)fst01158775
|
| 700 |
1 |
|
|a Galluzzi, Lorenzo.
|
| 700 |
1 |
|
|a Rudqvist, Nils-Petter.
|
| 776 |
0 |
8 |
|i Print version:
|t Tumor immunology and immunotherapy : Part A.
|b First edition.
|d Cambridge, MA : Academic Press, 2020
|z 9780128186732
|w (OCoLC)1139127784
|
| 830 |
|
0 |
|a Methods in enzymology ;
|v v. 631.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/00766879/631
|z Texto completo
|
| 880 |
0 |
0 |
|6 505-00/(S
|t Cytokine profiling of tumor-infiltrating T lymphocytes by flow cytometry /
|r Jeremy B. Foote, Sujith Sarvesh and Leisha A. Emens -- --
|t High-throughput identification of human antigen-specific CD8<SUP>+</SUP> and CD4<SUP>+</SUP> T cells using soluble pMHC multimers /
|r Morgane Magnin, Philippe Guillaume, George Coukos, Alexandre Harari and Julien Schmidt --
|t In vitro assays for effector T cell functions and activity of immunomodulatory antibodies /
|r Roberta Zappasodi, Sadna Budhu, Mohsen Abu-Akeel and Taha Merghoub --
|t A cytofluorimetric assay to evaluate T cell polyfunctionality /
|r Belinda Palermo, Mariangela Panetta, Giulia Campo and Paola Nistic�o --
|t Assessment of memory formation by metabolically engineered antigen-specific CD8 T cells /
|r Mathias Wenes, Pedro Romero and Lianjun Zhang --
|t Functional characterization of tumor antigen-specific T-cells isolated from the tumor microenvironment of sleeping beauty induced murine glioma models /
|r Mahmoud S. Alghamri, Felipe J. N�u�nez, Neha Kamran, Stephen Carney, David Altshuler, Pedro R. Lowenstein and Maria G. Castro --
|t Methods to edit T cells for cancer immunotherapy /
|r Francesca Lucibello, Silvia Menegatti and Laurie Menger --
|t Generating stem-like memory T cells with antioxidants for adoptive cell transfer immunotherapy of cancer /
|r Karolina Pilipow, Eloise Scamardella and Enrico Lugli --
|t Reverse immunology: From peptide sequence to tumor-killing human T-cell clones /
|r Christophe Vanhaver, Monica Gordon-Alonso, Alexandre Bayard, Maria Teresa Catanese, Didier Colau, Pierre van der Bruggen and Annika M. Bruger --
|t Generation of TCR-engineered reference cell samples to control T-cell assay performance /
|r Nicole Bidmon, C�ecile Gouttefangeas and Sjoerd H. van der Burg --
|t In vitro expansion of Vγ9Vδ2 T cells for immunotherapy /
|r Christian Peters, L�eonce Kouakanou, Hans-Heinrich Oberg, Daniela Wesch and Dieter Kabelitz --
|t CFSE dilution to study human T and NK cell proliferation in vitro /
|r I�nigo Terr�en, Ane Orrantia, Joana Vitall�e, Olatz Zenarruzabeitia and Francisco Borrego --
|t Rapid isolation and enrichment of mouse NK cells for experimental purposes /
|r Maite Alvarez, Maria C. Ochoa, Luna Minute, Ignacio Melero and Pedro Berraondo --
|t Assessment of NK cell-mediated cytotoxicity by flow cytometry after rapid, high-yield isolation from peripheral blood /
|r Peter Holicek, Iva Truxova, Lenka Kasikova, Sarka Vosahlikova, Cyril Salek, Jana Rakova, Monika Holubova, Daniel Lysak, Isabelle Cremer, Radek Spisek and Jitka Fucikova --
|t Two-dimensional dynamic evaluation of natural killer cell-mediated lysis of adherent target cells /
|r Alexandra Frazao, Louise Rethacker and Anne Caignard --
|t Rapid isolation of mouse ILCs from murine intestinal tissues /
|r Kyle Burrows, Pailin Chiaranunt, Louis Ngai and Arthur Mortha --
|t Detecting and analyzing murine innate lymphoid cells /
|r Alejandra Gomez-Cadena, Pedro Romero, Sara Trabanelli and Camilla Jandus --
|t A cytofluorimetric assay to evaluate intracellular cytokine applications of microfluidic devices in advancing NK-cell migration studies /
|r Xiaoou Ren, Abdulaziz Alamri, Jolly Hipolito, Francis Lin and Sam K.P. Kung --
|t Complementary approaches to study NKT cells in cancer /
|r Jay A. Berzofsky, Purevdorj B. Olkhanud and Masaki Terabe --
|t Assessment of IFN-γ and granzyme-B production by in sitro technology /
|r Claudia Galassi, Gwenola Manic, Martina Musella, Antonella Sistigu and Ilio Vitale --
|t Assessment of IFNγ responsiveness in patient-derived xenografts /
|r Jordan J. Cardenas, Camila Robles-Oteiza and Katerina Politi --
|t Real-time cell analysis (RTCA) to measure killer cell activity against adherent tumor cells in vitro/
|r Hans-Heinrich Oberg, Christian Peters, Dieter Kabelitz and Daniela Wesch --
|t Analysis of cancer cell-intrinsic immune regulation in response to CD8+ T cell attack /
|r Natalie J. Neubert, Laure Till�e, Christophe Martignier, Silvia A. Fuertes Marraco and Daniel E. Speiser --
|t A flow cytometry-based method to screen for modulators of tumor-specific T cell cytotoxicity /
|r Javier Santos, Jes�us Ogando, Rosa Ana Lacalle and Santos Ma�nes --
|t Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay /
|r Seila Lorenzo-Herrero, Christian Sordo-Bahamonde, Segundo Gonz�alez and Alejandro L�opez-Soto --
|t 51Cr-release to monitor NK cell cytotoxicity /
|r Leslie Elsner and Ralf Dressel.
|
